UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: April 12, 2017
Accession Number:
Submission Type:
CIK: 0001582554
Company Name: Matinas BioPharma Holdings, Inc.
File Number: 333-217106